134 related articles for article (PubMed ID: 68827)
1. Immunochemotherapy in 34 cases of oat cell carcinoma of the lung with 19 complete responses.
Israël L; Depierre A; Choffel C; Milleron B; Edelstein R
Cancer Treat Rep; 1977; 61(3):343-7. PubMed ID: 68827
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy versus chemoimmunotherapy with levamisole or Corynebacterium parvum in advanced lung cancer.
Chahinian AP; Goldberg J; Holland JF; Reisman A; Jaffrey IS; Mandel EM
Cancer Treat Rep; 1982 Jun; 66(6):1291-7. PubMed ID: 6282455
[TBL] [Abstract][Full Text] [Related]
3. Moderate to high dose cyclophosphamide and intercalated Corynebacterium parvum in patients with metastatic lung cancer.
Thatcher N; Honeybourne D; Wagstaff J; Carroll KB; Barber PV; Morrison JB; Crowther D
Br J Dis Chest; 1984 Jan; 78(1):89-97. PubMed ID: 6318791
[TBL] [Abstract][Full Text] [Related]
4. Chemo-immunotherapy for unresectable bronchogenic carcinoma.
Sarna GP; Lowitz BB; Haskell CM; Dorey FJ; Cline MJ
Cancer Treat Rep; 1978 May; 62(5):681-7. PubMed ID: 350397
[TBL] [Abstract][Full Text] [Related]
5. Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations.
Aisner J; Whitacre M; Van Echo DA; Wiernik PH
Cancer Treat Rep; 1982 Feb; 66(2):221-30. PubMed ID: 6275987
[TBL] [Abstract][Full Text] [Related]
6. Combination chemotherapy plus methanol extracted residue of bacillus Calmette-Guérin or Corynebacterium parvum in stage III lung cancer.
Bjornsson S; Takita H; Kuberka N; Preisler H; Catane H; Higby D; Henderson E
Cancer Treat Rep; 1978 Apr; 62(4):505-10. PubMed ID: 350388
[TBL] [Abstract][Full Text] [Related]
7. [Recent personal results in advanced bronchial cancer. Palliative immuno-chemotherapy. 63 cases].
Israel L; Depierre A
Ann Med Interne (Paris); 1976 Jan; 127(1):39-42. PubMed ID: 64125
[No Abstract] [Full Text] [Related]
8. Non-cross-resistant chemotherapy and consolidation radiotherapy for small cell carcinoma of the lung.
Young JA; Dillman RO; Seagren SL; Taetle R; Rentschler RE; Lea JW; Lehar TJ; Green MR; Stanton W; Mendelsohn J; Royston I
Cancer Treat Rep; 1982 Jun; 66(6):1399-401. PubMed ID: 6282459
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin, cisplatin, and Corynebacterium parvum in non-small cell bronchogenic carcinoma.
Drapkin R; Bjornsson S; Naeher C; Higby D; Caracandas J; Wallens WT; Kuberka N; Suh K; Siddiqi N; Henderson ES
Cancer Treat Rep; 1980; 64(12):1367-9. PubMed ID: 7193520
[TBL] [Abstract][Full Text] [Related]
10. Oat cell carcinoma of the lung: combination treatment with radiotherapy and cyclophosphamide, adriamycin, vincristine, and methotrexate.
Wittes RE; Hopfan S; Hilaris B; Golbey RB; Melamed M; Martini N
Cancer; 1977 Aug; 40(2):653-9. PubMed ID: 196737
[No Abstract] [Full Text] [Related]
11. [Adriamycin-combination chemotherapy with or without immune stimulation by corynebacterium parvum in metastasizing carcinoma of the breast (author's transl)].
Mayr AC; Senn HJ; Gallmeier WM; Bruntsch U; Becher R; Drings P; Fritze D; Kaufmann M; Queisser W; Kempgens U
Dtsch Med Wochenschr; 1979 Dec; 104(49):1739-43. PubMed ID: 510206
[TBL] [Abstract][Full Text] [Related]
12. CCNU, vincristine, methotrexate, and procarbazine treatment of relapsed small cell lung carcinoma.
Poplin EA; Aisner J; Van Echo DA; Whitacre M; Wiernik PH
Cancer Treat Rep; 1982 Jul; 66(7):1557-9. PubMed ID: 6284360
[TBL] [Abstract][Full Text] [Related]
13. Long-term results in combined-modality treatment of small cell carcinoma of the lung.
Einhorn LH; Bond WH; Hornback N; Joe BT
Semin Oncol; 1978 Sep; 5(3):309-13. PubMed ID: 211642
[TBL] [Abstract][Full Text] [Related]
14. Intensive induction therapy for small cell carcinoma of the lung.
Abeloff MD; Ettinger DS; Khouri NF; Lenhard RE
Cancer Treat Rep; 1979 Apr; 63(4):519-24. PubMed ID: 221117
[TBL] [Abstract][Full Text] [Related]
15. Combined therapy for small cell undifferentiated carcinoma of the lung.
Mandelbaum I; Williams SD; Hornback NB; Joe BT; Einhorn LH
J Thorac Cardiovasc Surg; 1978 Sep; 76(3):292-6. PubMed ID: 210332
[TBL] [Abstract][Full Text] [Related]
16. Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphoma.
Musolino A; Perrone MA; Michiara M; Delnevo D; Franciosi V; Di Blasio B; Ceci G; Camisa R; Ardizzoni A; Cocconi G
Cancer; 2005 May; 103(10):2109-17. PubMed ID: 15803492
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin, vincristine, bleomycin, cytembena and cisplatin as combination chemotherapy for squamous cell lung cancer.
Georgoulias V; Misset JL; Ribaud P; Machover D; De Vassal F; Dorval T; Musset M; Schwarzenberg L; Reizenstein P; Mathe G; Gaget H
Anticancer Res; 1983; 3(2):107-10. PubMed ID: 6189445
[TBL] [Abstract][Full Text] [Related]
18. First, second and third line chemotherapy programs in metastatic breast carcinoma.
Rizel S; Sulkes A; Gez E; Brufman G; Biran S
Isr J Med Sci; 1981; 17(9-10):946-53. PubMed ID: 6171542
[TBL] [Abstract][Full Text] [Related]
19. Combination chemoimmunotherapy for advanced renal carcinoma with Adriamycin, bleomycin, vincristine, cyclophosphamide, plus BCG.
Dana BW; Alberts DS
Cancer Clin Trials; 1981; 4(2):205-7. PubMed ID: 6166407
[TBL] [Abstract][Full Text] [Related]
20. Cyclophosphamide, vincristine, lomustine, cisplatin, and doxorubicin in the treatment of non-small cell lung cancer.
Pearlman NW; Meyers TJ; Siebert PE; Wallner SF; Carson SD; Campbell DN; Johnson FB; Kennaugh R; Rempel P
Cancer Treat Rep; 1983 Apr; 67(4):375-6. PubMed ID: 6303587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
